Notice Information
Notice Title
Untargeted metabolomics of cell-free media from suspension-adapted cells producing adeno-associated viruses
Notice Description
Cell Therapy Catapult Ltd is seeking through this Open Tender Process to contract with a suitably capable Bidder to provide the Services for the untargeted metabolomics of cell-free media from suspension-adapted cells producing adeno-associated viral vectors (AAV). Briefly, human cells will be subjected to AAV production in parallel with controls. A maximum of 35 sample and two medium controls will be generated in this experiment, designated as "Run 1", and sent to the awarded Bidder each as technical replicates (maximum 3 per sample). The samples will then be processed by the awarded Bidder as per requirements detailed in Specification (Appendix B). In addition to "Run 1", two additional runs ("Run 2" and "Run 3") may be performed at our sole discretion. Importantly, the experimental setup for both "Run 2" and "Run 3" will be similar to that for "Run 1", but sample numbers may differ if additional conditions are included or excluded. A maximum of 37 samples (i.e., including medium controls) will be obtained for either "Run 2" and "Run 3". Subsequent runs or analysis may be performed, contingent on the results obtained from the 3 planned runs. This will be to ensure robustness of the findings or to meet unforeseen project needs. This will be based on satisfactory performance and continued need.
Lot Information
Lot 1
Cell Therapy Catapult Ltd is seeking through this Open Tender Process to contract with a suitably capable Bidder to provide the Services for the untargeted metabolomics of cell-free media from suspension-adapted cells producing adeno-associated viral vectors (AAV). Briefly, human cells will be subjected to AAV production in parallel with controls. A maximum of 35 sample and two medium controls will be generated in this experiment, designated as "Run 1", and sent to the awarded Bidder each as technical replicates (maximum 3 per sample). The samples will then be processed by the awarded Bidder as per requirements detailed in Specification (Appendix B). In addition to "Run 1", two additional runs ("Run 2" and "Run 3") may be performed at our sole discretion. Importantly, the experimental setup for both "Run 2" and "Run 3" will be similar to that for "Run 1", but sample numbers may differ if additional conditions are included or excluded. A maximum of 37 samples (i.e., including medium controls) will be obtained for either "Run 2" and "Run 3". Subsequent runs or analysis may be performed, contingent on the results obtained from the 3 planned runs. This will be to ensure robustness of the findings or to meet unforeseen project needs. This will be based on satisfactory performance and continued need.
Renewal: The proposed contract will be for a period of up to 6 months, with the option to extend, subject to satisfactory performance and continued need, for three additional 6-month periods (6 months + 6 months + 6 months + 6 months). The contract length will not exceed 2 (two) years.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-037448
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/028371-2022
- Current Stage
- Tender
- All Stages
- Tender
Procurement Classification
- Notice Type
- Tender Notice
- Procurement Type
- Standard
- Procurement Category
- Services
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Not specified
Common Procurement Vocabulary (CPV)
- CPV Divisions
71 - Architectural, construction, engineering and inspection services
73 - Research and development services and related consultancy services
-
- CPV Codes
71900000 - Laboratory services
73100000 - Research and experimental development services
73111000 - Research laboratory services
73300000 - Design and execution of research and development
Notice Value(s)
- Tender Value
- £180,000 £100K-£500K
- Lots Value
- £180,000 £100K-£500K
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 10 Oct 20223 years ago
- Submission Deadline
- 10 Nov 2022Expired
- Future Notice Date
- Not specified
- Award Date
- Not specified
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Active
- Lots Status
- Active
- Awards Status
- Not Specified
- Contracts Status
- Not Specified
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- CELL AND GENE THERAPY CATAPULT
- Contact Name
- Not specified
- Contact Email
- procurement@ct.catapult.org.uk
- Contact Phone
- Not specified
Buyer Location
- Locality
- LONDON
- Postcode
- SE1 9RT
- Post Town
- South East London
- Country
- England
-
- Major Region (ITL 1)
- TLI London
- Basic Region (ITL 2)
- TLI4 Inner London - East
- Small Region (ITL 3)
- TLI44 Lewisham and Southwark
- Delivery Location
- TLI London
-
- Local Authority
- Southwark
- Electoral Ward
- London Bridge & West Bermondsey
- Westminster Constituency
- Bermondsey and Old Southwark
Further Information
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-037448-2022-10-10T11:06:32+01:00",
"date": "2022-10-10T11:06:32+01:00",
"ocid": "ocds-h6vhtk-037448",
"initiationType": "tender",
"tender": {
"id": "ocds-h6vhtk-037448",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "Untargeted metabolomics of cell-free media from suspension-adapted cells producing adeno-associated viruses",
"status": "active",
"classification": {
"scheme": "CPV",
"id": "73111000",
"description": "Research laboratory services"
},
"mainProcurementCategory": "services",
"description": "Cell Therapy Catapult Ltd is seeking through this Open Tender Process to contract with a suitably capable Bidder to provide the Services for the untargeted metabolomics of cell-free media from suspension-adapted cells producing adeno-associated viral vectors (AAV). Briefly, human cells will be subjected to AAV production in parallel with controls. A maximum of 35 sample and two medium controls will be generated in this experiment, designated as \"Run 1\", and sent to the awarded Bidder each as technical replicates (maximum 3 per sample). The samples will then be processed by the awarded Bidder as per requirements detailed in Specification (Appendix B). In addition to \"Run 1\", two additional runs (\"Run 2\" and \"Run 3\") may be performed at our sole discretion. Importantly, the experimental setup for both \"Run 2\" and \"Run 3\" will be similar to that for \"Run 1\", but sample numbers may differ if additional conditions are included or excluded. A maximum of 37 samples (i.e., including medium controls) will be obtained for either \"Run 2\" and \"Run 3\". Subsequent runs or analysis may be performed, contingent on the results obtained from the 3 planned runs. This will be to ensure robustness of the findings or to meet unforeseen project needs. This will be based on satisfactory performance and continued need.",
"value": {
"amount": 180000,
"currency": "GBP"
},
"lots": [
{
"id": "1",
"description": "Cell Therapy Catapult Ltd is seeking through this Open Tender Process to contract with a suitably capable Bidder to provide the Services for the untargeted metabolomics of cell-free media from suspension-adapted cells producing adeno-associated viral vectors (AAV). Briefly, human cells will be subjected to AAV production in parallel with controls. A maximum of 35 sample and two medium controls will be generated in this experiment, designated as \"Run 1\", and sent to the awarded Bidder each as technical replicates (maximum 3 per sample). The samples will then be processed by the awarded Bidder as per requirements detailed in Specification (Appendix B). In addition to \"Run 1\", two additional runs (\"Run 2\" and \"Run 3\") may be performed at our sole discretion. Importantly, the experimental setup for both \"Run 2\" and \"Run 3\" will be similar to that for \"Run 1\", but sample numbers may differ if additional conditions are included or excluded. A maximum of 37 samples (i.e., including medium controls) will be obtained for either \"Run 2\" and \"Run 3\". Subsequent runs or analysis may be performed, contingent on the results obtained from the 3 planned runs. This will be to ensure robustness of the findings or to meet unforeseen project needs. This will be based on satisfactory performance and continued need.",
"value": {
"amount": 180000,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 180
},
"hasRenewal": true,
"renewal": {
"description": "The proposed contract will be for a period of up to 6 months, with the option to extend, subject to satisfactory performance and continued need, for three additional 6-month periods (6 months + 6 months + 6 months + 6 months). The contract length will not exceed 2 (two) years."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
}
],
"items": [
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "71900000",
"description": "Laboratory services"
},
{
"scheme": "CPV",
"id": "73100000",
"description": "Research and experimental development services"
},
{
"scheme": "CPV",
"id": "73300000",
"description": "Design and execution of research and development"
}
],
"deliveryAddresses": [
{
"region": "UKI"
}
],
"relatedLot": "1"
}
],
"submissionMethod": [
"electronicSubmission",
"written"
],
"submissionMethodDetails": "https://catapultcgtc.wax-live.com/S2C/DisplayModules/TradeModules/Negotiations/Opportunities/ViewEvent.aspx?EventID=296&ApplicationInstanceID=27adc89e-0cb2-4b51-9bc1-34061f10156f",
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"coveredBy": [
"GPA"
],
"tenderPeriod": {
"endDate": "2022-11-10T12:00:00Z"
},
"submissionTerms": {
"languages": [
"en"
]
},
"awardPeriod": {
"startDate": "2022-11-10T12:01:00Z"
},
"bidOpening": {
"date": "2022-11-10T12:01:00Z"
},
"hasRecurrence": false
},
"parties": [
{
"id": "GB-COH-10016023",
"name": "CELL AND GENE THERAPY CATAPULT",
"identifier": {
"legalName": "CELL AND GENE THERAPY CATAPULT",
"id": "10016023",
"scheme": "GB-COH"
},
"address": {
"streetAddress": "12TH FLOOR TOWER WING,GUY'S HOSPITAL, GREAT MAZE POND",
"locality": "LONDON",
"region": "UKI44",
"postalCode": "SE19RT",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "procurement@ct.catapult.org.uk",
"url": "https://catapultcgtc.wax-live.com/S2C/DisplayModules/TradeModules/Negotiations/Opportunities/ViewEvent.aspx?EventID=296&ApplicationInstanceID=27adc89e-0cb2-4b51-9bc1-34061f10156f"
},
"roles": [
"buyer"
],
"details": {
"url": "https://ct.catapult.org.uk/",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "BODY_PUBLIC",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
},
{
"id": "GB-FTS-63411",
"name": "Cell and Gene Therapy Catapult",
"identifier": {
"legalName": "Cell and Gene Therapy Catapult"
},
"address": {
"locality": "London",
"countryName": "United Kingdom"
},
"roles": [
"reviewBody"
]
}
],
"buyer": {
"id": "GB-COH-10016023",
"name": "CELL AND GENE THERAPY CATAPULT"
},
"language": "en"
}